Back to Search
Start Over
Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria
- Source :
- Baumann , K , Jørgensen , A H R , Sørensen , J A , Zhang , D G , Ghazanfar , M N , Skov , P S , Woetmann , A , Vestergaard , C , Maurer , M & Thomsen , S F 2023 , ' Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria ' , Clinical and Experimental Allergy , vol. 53 , no. 12 , pp. 1318-1321 .
- Publication Year :
- 2023
Details
- Database :
- OAIster
- Journal :
- Baumann , K , Jørgensen , A H R , Sørensen , J A , Zhang , D G , Ghazanfar , M N , Skov , P S , Woetmann , A , Vestergaard , C , Maurer , M & Thomsen , S F 2023 , ' Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria ' , Clinical and Experimental Allergy , vol. 53 , no. 12 , pp. 1318-1321 .
- Notes :
- application/pdf, English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1439550662
- Document Type :
- Electronic Resource